METASTATIC ALVEOLAR SOFT PART SARCOMA
Clinical trials for METASTATIC ALVEOLAR SOFT PART SARCOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC ALVEOLAR SOFT PART SARCOMA trials appear
Sign up with your email to follow new studies for METASTATIC ALVEOLAR SOFT PART SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare sarcoma: drug duo targets tumors
Disease control Recruiting nowThis study tests whether combining two drugs, atezolizumab and selinexor, can shrink tumors in people with a rare cancer called alveolar soft part sarcoma (ASPS). About 27 adults with advanced or spreading ASPS will receive the combination. The goal is to see if this approach wor…
Matched conditions: METASTATIC ALVEOLAR SOFT PART SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could less be more? new study tests lower doses of cancer drug
Disease control Recruiting nowThis study is testing whether giving lower, less frequent doses of the cancer drug atezolizumab can still keep enough drug in the blood to fight cancer. About 30 adults with certain advanced cancers (like lung cancer or melanoma) will start with standard doses, then switch to a l…
Matched conditions: METASTATIC ALVEOLAR SOFT PART SARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC